Researchers have combined two sequencing technologies in single cells to find new differences in mRNAs resulting from Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease. Diseases ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic Unity ® 2.0, a novel whole genome-based diagnostic test. This advanced test ...